We are live on ! Find out more
BCM

Beryl Capital Management Portfolio holdings

AUM $110M
1-Year Est. Return 317.92%
This Fund
S&P 500
This Quarter Est. Return
+54.26%
1 Year Est. Return
+317.92%
3 Year Est. Return
+5,124.04%
5 Year Est. Return
+10,319.28%
10 Year Est. Return
AUM
$664M
AUM Growth
+$396M
Cap. Flow
+$304M
Cap. Flow %
45.82%
Top 10 Hldgs %
89.46%
Holding
39
New
26
Increased
1
Reduced
1
Closed
11

Sector Composition

Rank Sector Weight
1 Healthcare 46.16%
2 Consumer Discretionary 26.62%
3 Financials 12.26%
4 Technology 10.91%
5 Industrials 2.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIOT icon
26
Riot Platforms
RIOT
$8.56B
$565K 0.09%
+50,000
New +$425K
TGI
27
DELISTED
Triumph Group
TGI
$238K 0.04%
+9,225
New +$235K
BGFV
28
DELISTED
Big 5 Sporting Goods
BGFV
$202K 0.03%
+142,454
New +$153K
CKPT
29
DELISTED
Checkpoint Therapeutics
CKPT
-6,074,216
Closed -$24.5M
SGRP
30
DELISTED
SPAR Group
SGRP
-280,449
Closed -$370K
TSVT
31
DELISTED
2seventy bio
TSVT
-4,250,000
Closed -$21M
WULF icon
32
TeraWulf
WULF
$9.18B
-253,430
Closed -$692K
BECN
33
DELISTED
Beacon Roofing Supply, Inc.
BECN
-404,476
Closed -$50M
CMRX
34
DELISTED
Chimerix, Inc.
CMRX
-3,927,238
Closed -$33.4M
PDCO
35
DELISTED
Patterson Companies, Inc.
PDCO
-103,701
Closed -$3.24M
LGTY
36
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
-950,672
Closed -$13.6M
NVRO
37
DELISTED
NEVRO CORP.
NVRO
-3,761,191
Closed -$22M
ITCI
38
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-541,642
Closed -$71.5M
VCSA
39
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
-18,896
Closed -$102K

Similar funds

Beryl Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Beryl Capital Management held 39 positions worth $664M, up 148% from $268M the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Beryl Capital Management deployed $304M of net new capital in Q2 2025, opening 26 new positions and adding to 1 existing holding. Its largest new stake was Skechers: 2,154,898 shares worth $136M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 66% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Lifeway Foods, an estimated $3.82M trimmed.

  • Beryl Capital Management's largest Q2 2025 buy was Skechers: 2,154,898 shares worth $136M.
  • Beryl Capital Management added most to Dun & Bradstreet in Q2 2025, an estimated $42.8M increase.
  • Beryl Capital Management's biggest Q2 2025 reduction was Lifeway Foods, cutting an estimated $3.82M.
  • Beryl Capital Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $71.5M.
  • Beryl Capital Management's ten largest holdings make up 89% of its $664M portfolio in Q2 2025.
  • Beryl Capital Management opened 26 new positions and closed 11 in Q2 2025.
  • Beryl Capital Management's portfolio value rose 148% quarter-over-quarter to $664M.

Based on Beryl Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.